DOSSIER · 13F Holders · Q2 2026Healthcare · Drug Manufacturers - General
LLY

ELI LILLY & CO

4,750 institutions still hold ELI LILLY & CO as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 532457108·Drug Manufacturers - General·4,750 13F holders·last filed Jun 30, 2026
Market cap
$850.0B
13F value held
$537.3B
visible holders
Holders
4,750
filers reporting
Concentration
20.18%
LILLY ENDOWMENT INC #1
top holder share
AI Holders Summary · Q2 2026

LLY registers 4,219 institutional filers with roughly $647 billion in combined 13F value, but the register has a distinctive owner at its apex: Lilly Endowment Inc, founded by Eli Lilly himself, sits at the top with roughly $84 billion—a uniquely concentrated founder-linked position that is almost unheard of in the S&P 500. Beneath it, healthcare-oriented active managers like Capital Research Global Investors and FMR maintain deliberate allocations, while passive vehicles continue their standard broad-market loading.

The passive core follows standard patterns. BlackRock ($61.2 billion), Vanguard Capital Management ($49.1 billion), State Street ($32.8 billion), FMR/Fidelity ($24.2 billion), and Geode ($18.5 billion) form the typical passive-majority top tier. Vanguard Portfolio Management added LLY as a new position this quarter, indicating that an ETF or sleeve rebalance pulled the name into a vehicle that previously did not hold it.

The more informative register read is in the active-manager tier. Capital Research Global Investors extended its position slightly—shares up modestly, signaling an active upgrade. FMR/Fidelity added roughly $613 million in notional value. JPMorgan grew its stake by about $1.8 billion, and Wellington Management added roughly $2.0 billion. These four names are healthcare-oriented or balanced-growth allocators with fundamental research infrastructure dedicated to pharmaceutical and biotech sector analysis; their collective behavior carries more weight than a generic large-cap active manager's LLY position.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
LILLY ENDOWMENT INC
CIK 0000316011
$108.4B90.4M100.00%Q2 2026
02
BlackRock, Inc.
CIK 0002012383
$81.0B67.5M1.20%Q2 2026
03
PNC FINANCIAL SERVICES GROUP, INC.
CIK 0000713676
$54.9B51.1M32.97%Q4 2025
04
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$49.1B53.4M1.21%Q1 2026
05
STATE STREET CORP
CIK 0000093751
$43.4B36.2M1.29%Q2 2026
06
FMR LLC
CIK 0000315066
$24.2B26.3M1.28%Q1 2026
07
Capital Research Global Investors
CIK 0001422848
$22.7B24.6M3.51%Q1 2026
08
Vanguard Portfolio Management
CIK 0002100121· Index
$19.3B21.0M1.01%Q1 2026
09
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$18.5B20.2M1.15%Q1 2026
10
Capital World Investors
CIK 0001422849
$14.4B15.6M1.96%Q1 2026
11
MORGAN STANLEY
CIK 0000895421
$14.2B15.4M0.86%Q1 2026
12
PRICE T ROWE ASSOCIATES INC /MD/
CIK 0000080255
$12.9B14.0M1.49%Q1 2026
13
WELLINGTON MANAGEMENT GROUP LLP
CIK 0000902219
$12.3B13.4M2.31%Q1 2026
14
JPMORGAN CHASE & CO
CIK 0000019617
$12.1B13.7M0.78%Q1 2026
15
BANK OF AMERICA CORP /DE/
CIK 0000070858
$10.2B11.1M0.75%Q1 2026
16
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO
CIK 0000315032
$9.9B10.8M7.80%Q1 2026
17
PRIMECAP MANAGEMENT CO/CA/
CIK 0000763212
$8.5B9.2M6.68%Q1 2026
18
NORTHERN TRUST CORP
CIK 0000073124· Index
$8.1B8.8M1.07%Q1 2026
19
JENNISON ASSOCIATES LLC
CIK 0000053417
$6.6B5.5M3.93%Q2 2026
20
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
CIK 0000861177
$6.5B7.1M1.35%Q1 2026
Page 1 of 238
4730 more holders available. Log in →
Insiders at ELI LILLY & CO
Luciano Juan RSulzberger GabrielleAlvarez RalphFyrwald J ErikYuffa IlyaSkovronsky DanielVan Naarden JacobZakrowski Donald A